Dose Escalation with Three-dimensional Conformal Radiotherapy for Prostate Cancer. Is More Dose Really Better in High-risk Patients Treated with Androgen Deprivation?

The present study indicates an independent benefit on biochemical outcome of high-dose 3DCRT for low-, intermediate- and high-risk patients and of long-term AAD in high-risk prostate cancer patients.